Glu Asp Val Asp - CAS号查询

热门搜索化学品最多只显示前20条，请点击“搜索化学品”查看所有结果

CAS登录号

中文名

英文名

分子结构式

分子式

详情

供应商

169332-61-0

Ac-Asp-Glu-Val-Asp-7-氨基-4-甲基香豆素

L-a-Asparagine, N-acetyl-L-a-Aspartyl-L-a-Glutamyl-L-Valyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-;
L-a-Asparagine,N2-[N-[N-(N-acetyl-L-a-Aspartyl)-L-a-Glutamyl]-L-Valyl]-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-

Ac-DEVD-pNA

L-Asparagine,N-acetyl-L-a-Aspartyl-L-a-Glutamyl-L-Valyl-N-(4-nitrophenyl)-(9CI);
CAspASE 3 (APOPAIN) SUBSTRATE 1, CHROMOGENIC;
CAspASE-3 SUBSTRATE VIII, WATER-SOLUBLE, COLORIMETRIC;
CAspASE 3/CPP32 CHROMOGENIC SUBSTRATE;
CAspASE-3 SUBSTRATE (CHROMOGENIC);
CAspASE-3 SUBSTRATE I, COLORIMETRIC;
CHROMOGENIC CAspASE 3 SUBSTRATE AC-DEVD-PNA;
AC-Asp-Glu-Val-Asp-PARANITROANILIDE;
AC-Asp-Glu-Val-Asp-PNA

半胱胺酸蛋白酶-10;
半胱胺酸蛋白酶-10(抗体);
半胱胺酸蛋白酶-10(抗原)

L-Valinamide,N-acetyl-L-a-Aspartyl-L-a-Glutamyl-N-(2-carboxy-1-formylethyl)-(9CI);
DEVD-CHO;
CPP32/APOPAIN INHIBITOR;
CPP32/APOPAIN INHIBITOR, CELL-PERMEABLE;
CAspASE 3 (APOPAIN) INHIBITOR 1;
CAspASE-3 INHIBITOR I;
CAspASE-3 INHIBITOR I, CELL-PERMEABLE;
CAspASE-3 INHIBITOR;
CAspASE-3 INHIBITOR (ALDEHYDE)

L-Threonine, L-a-Glutamyl-L-isoleucyl-L-leucyl-L-a-Aspartyl-L-Valyl-L-prolyl-L-seryl-;
L-Threonine, N-[N-[1-[N-[N-[N-(N-L-a-Glutamyl-L-isoleucyl)-L-leucyl]-L-a-Aspartyl]-L-Valyl]-L-prolyl]-L-seryl]-;
10: PN:WO03074722 SEQID: 10 unclaimed sequence;
13: PN: WO2005033275 SEQID: 22unclaimed sequence;
1: PN: US6376538 SEQID: 1 unclaimed sequence;
1: PN:WO0064474 PAGE: 19 unclaimed sequence;
22: PN: WO03019136 SEQID: 22 claimedsequence;
24: PN: WO0004941 PAGE: 32 claimed sequence;
35: PN: US6376248 SEQID:48 unclaimed sequence;
458: PN: WO0069900 SEQID: 1143 unclaimed sequence;
47:PN: US6051429 SEQID: 48 unclaimed sequence;
76: PN: US20030119021 SEQID: 55unclaimed sequence;
897: PN: US20090175821 SEQID: 1143 claimed protein;
8: PN:WO2008140602 SEQID: 11 unclaimed protein;
9: PN: WO2005023981 SEQID: 10unclaimed sequence

L-Valinamide,L-phenylalanyl-D-Asparaginyl-L-a-Glutamyl-L-phenylalanyl- (9CI);
Fulicin

L-Phenylalaninamide,L-threonyl-L-Asparaginyl-L-Valylglycyl-L-seryl-L-a-Glutamyl-L-alanyl-;
CGRP-(30-37);
Calcitonin gene-related peptide fragment;
Rat calcitonin gene related peptide30-37

L-Serine,L-methionyl-L-Glutaminyl-L-methionyl-L-Asparaginyl-L-lysyl-L-Valyl-L-leucyl-L-a-Aspartyl-;
L-Serine,N-[N-[N-[N-[N2-[N2-[N-(N2-L-methionyl-L-Glutaminyl)-L-methionyl]-L-Asparaginyl]-L-lysyl]-L-Valyl]-L-leucyl]-L-a-Aspartyl]-;
14: PN: WO0062795PAGE: 35 unclaimed sequence;
1: PN: WO2009033790 PAGE: 100 claimed protein

L-Lysine,L-Valyl-L-Glutaminylglycyl-L-a-Glutamyl-L-a-Glutamyl-L-seryl-L-Asparaginyl-L-a-Aspartyl-;
L-Lysine,N2-[N-[N2-[N-[N-[N-[N-(N2-L-Valyl-L-Glutaminyl)glycyl]-L-a-Glutamyl]-L-a-Glutamyl]-L-seryl]-L-Asparaginyl]-L-a-Aspartyl]-;
13: PN:US20060257420 SEQID: 13 claimed protein;
13: PN: WO0136448 SEQID: 13 claimedsequence;
13: PN: WO2009114869 SEQID: 13 claimed protein;
14: PN: US20040170972PAGE: 20 claimed sequence;
15: PN: US20050282263 SEQID: 15 claimed sequence;
15: PN: WO03103605 SEQID: 15 claimed protein;
15: PN: WO2005091753 SEQID: 15claimed sequence;
1: PN: US20020088025 SEQID: 30 unclaimed sequence;
1: PN:US20050153873 PAGE: 9 unclaimed sequence;
29: PN: WO2009042538 SEQID: 15unclaimed protein;
2: PN: US20030003440 SEQID: 6 unclaimed sequence;
31: PN:US20030126631 SEQID: 22 unclaimed sequence;
35: PN: WO0189286 SEQID: 35 claimedsequence;
568: PN: WO0069900 SEQID: 1258 unclaimed sequence;
5: PN: WO2004014945PAGE: 9 unclaimed sequence;
995: PN: US20090175821 SEQID: 1258 claimed protein

L-Serine,L-methionyl-L-Glutaminyl-L-methionyl-L-lysyl-L-lysyl-L-Valyl-L-leucyl-L-a-Aspartyl-;
L-Serine,N-[N-[N-[N-[N2-[N2-[N-(N2-L-methionyl-L-Glutaminyl)-L-methionyl]-L-lysyl]-L-lysyl]-L-Valyl]-L-leucyl]-L-a-Aspartyl]-;
16: PN: WO0062795PAGE: 35 unclaimed sequence;
1: PN: WO2009033718 PAGE: 102 claimed protein;
2:PN: WO2006031117 SEQID: 8 unclaimed sequence;
65: PN: WO2008058016 SEQID: 65claimed protein;
Antiflammin 1;
Antiflammin P 1

L-Phenylalaninamide,L-Valyl-L-prolyl-L-Asparaginyl-L-leucyl-L-prolyl-L-Glutaminyl-L-arginyl-;
NeuropeptideNPVF-amide;
Neuropeptide VF;
Rat RFRP-3

L-Methionine,L-Valyl-L-prolyl-L-Valyl-L-a-Glutamyl-L-alanyl-L-Valyl-L-a-Aspartyl-L-prolyl-;
L-Methionine,N-[1-[N-[N-[N-[N-[N-(1-L-Valyl-L-prolyl)-L-Valyl]-L-a-Glutamyl]-L-alanyl]-L-Valyl]-L-a-Aspartyl]-L-prolyl]-;
232: PN:WO0069900 SEQID: 413 unclaimed sequence;
335: PN: US20090175821 SEQID: 413claimed protein

L-a-Asparagine, N-acetyl-L-Valyl-L-a-Glutamyl-L-isoleucyl-N-(4-nitrophenyl)-;
CAspASE-6 SUBSTRATE II, COLORIMETRIC;
CAspASE-6 SUBSTRATE (CHROMOGENIC);
CAspASE 6 (MCH2) SUBSTRATE 1, CHROMOGENIC;
AC-Val-Glu-ILE-Asp-PARANITROANILIDE;
AC-Val-Glu-ILE-Asp-PNA;
AC-VEID-PNA;
N-ACETYL-Val-Glu-ILE-Asp-P-NITROANILIDE;
N-ACETYL-Val-Glu-ILE-Asp-P-NITROANILIDE PNA

L-Valine,L-Valyl-L-leucyl-L-Glutaminyl-L-a-Glutamyl-L-leucyl-L-Asparaginyl-L-Valyl-L-threonyl-;
L-Valine,N-[N-[N-[N2-[N-[N-[N2-(N-L-Valyl-L-leucyl)-L-Glutaminyl]-L-a-Glutamyl]-L-leucyl]-L-Asparaginyl]-L-Valyl]-L-threonyl]-;
11: PN: WO2006026746 SEQID: 12 unclaimed sequence;
18: PN: WO2008083174 SEQID:26 claimed protein;
19: PN: WO2005035714 SEQID: 1 claimed sequence;
1: PN:US20060045881 SEQID: 1 claimed sequence;
1: PN: US20060045883 SEQID: 1 claimedsequence;
1: PN: US20060045884 SEQID: 1 claimed sequence;
1: PN: WO2004110481SEQID: 1 unclaimed sequence;
1: PN: WO2009102909 SEQID: 1 claimed protein;
2:PN: WO2008058016 SEQID: 2 claimed protein;
33: PN: WO2009059804 SEQID: 33claimed protein;
49: PN: WO2004084936 SEQID: 50 unclaimed sequence;
50: PN:WO2005009463 SEQID: 50 unclaimed protein;
56: PN: WO2009026547 SEQID: 70unclaimed protein;
61: PN: WO2005071088 SEQID: 63 unclaimed sequence;
63: PN:US20050249748 SEQID: 63 unclaimed sequence;
70: PN: US20090075304 SEQID: 70unclaimed sequence;
70: PN: US20090233318 SEQID: 70 unclaimed sequence;
70: PN:US20090304679 SEQID: 70 claimed protei

L-Histidine,L-Glutaminyl-L-a-Aspartyl-L-Valyl-(9CI);
L-Histidine,N-[N-(N-L-Glutaminyl-L-a-Aspartyl)-L-Valyl]-;
2: PN: WO2005120554 SEQID: 1 claimed protein;
HumanPTH-(29-32)

L-Tyrosine, L-a-Glutamyl-L-Valyl-L-a-Aspartyl-L-prolyl-L-isoleucylglycyl-L-histidyl-L-leucyl-;
L-Tyrosine,N-[N-[N-[N-[N-[1-[N-(N-L-a-Glutamyl-L-Valyl)-L-a-Aspartyl]-L-prolyl]-L-isoleucyl]glycyl]-L-histidyl]-L-leucyl]-;
10: PN:WO0049041 SEQID: 13 claimed sequence;
10: PN: WO0050589 SEQID: 10 unclaimedsequence;
10: PN: WO2008019018 SEQID: 8 unclaimed sequence;
113: PN: WO2004071457SEQID: 140 unclaimed sequence;
114: PN: US7420037 SEQID: 119 unclaimed protein;
11: PN: US6291430 SEQID: 47 unclaimed sequence;
11: PN: WO0006598 SEQID: 12unclaimed sequence;
12: PN: US6245525 SEQID: 6 unclaimed sequence;
12: PN:WO0053161 SEQID: 51 unclaimed sequence;
12: PN: WO0216560 SEQID: 44 unclaimedsequence;
12: PN: WO2004029071 SEQID: 11 claimed sequence;
1378: PN:WO2006091734 PAGE: 74 claimed sequence;
13: PN: US20040033541 SEQID: 13unclaimed sequence;
13: PN: US20090042285 SEQID: 13 claimed protein;
13: PN:US20090226474 SEQID: 13 unclaimed protein;
13: PN: WO0020445 SEQID: 3 unclaimedsequence;
13: PN: WO0050077 SEQID: 13 claimed sequence;
13: PN: WO0129220SEQID: 11 unclaimed sequence;
141: PN: WO

L-Proline,L-Glutaminyl-L-Valyl-L-prolyl-L-seryl-L-arginyl-L-prolyl-L-Asparaginyl-L-arginyl-L-alanyl-;
1: PN:WO9962494 SEQID: 1 claimed sequence

L-Valinamide,N-acetyl-L-a-Aspartyl-L-a-Glutamyl-N-[(1S)-2-carboxy-1-formylethyl]-;
L-Valinamide,N-acetyl-L-a-Aspartyl-L-a-Glutamyl-N-(2-carboxy-1-formylethyl)-,(S)-;
17: PN: WO2005039629 PAGE: 18 claimed protein;
1: PN: WO0009664 PAGE: 33claimed protein;
4: PN: WO0158526 SEQID: 4 claimed sequence;
L 761191;
MF 191

L-Valinamide,N-acetyl-L-seryl-L-Glutaminyl-L-Asparaginyl-L-tyrosyl-L-prolyl-L-Valyl- (9CI);
AC-SER-GLN-ASN-TYR-PRO-Val-Val-NH2;
ACETYL-SER-GLN-ASN-TYR-PRO-Val-Val AMIDE

L-Phenylalaninamide,L-Asparaginyl-L-Valylglycyl-L-seryl-L-a-Glutamyl-L-alanyl- (9CI);
CGRP-(31-37)

L-Valine,L-lysyl-L-Glutaminyl-L-alanylglycyl-L-a-Aspartyl-;
L-Valine,N-[N-[N-[N-(N2-L-lysyl-L-Glutaminyl)-L-alanyl]glycyl]-L-a-Aspartyl]-;
14: PN: WO2009120895SEQID: 14 claimed sequence;
20: PN: US20020198360 SEQID: 1 unclaimed sequence;
2: PN: WO0045856 PAGE: 199 claimed protein;
2: PN: WO2004072289 SEQID: 10unclaimed sequence;
31: PN: WO2010005513 SEQID: 30 claimed protein;
4: PN:US20060029544 PAGE: 7 unclaimed sequence;
4: PN: US6521211 PAGE: 151 claimedprotein;
4: PN: WO2004108888 SEQID: 5 unclaimed sequence;
5: PN: DE10119096PAGE: 10 claimed sequence;
88: PN: WO03072542 SEQID: 93 claimed sequence;
Fibrinogen g-chain fragment

C25H44N8O10

详情

供应商

化工产品